← Back
Data updated: Mar 10, 2026
VELZEN PHARMA PVT
Cardiovascular
VELZEN PHARMA PVT is a generic drug manufacturer focused on Cardiovascular. Key products include GLYCOPYRROLATE.
1991
Since
4
Drugs
-
Trials
30
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
GLYCOPYRROLATE 2026-02-10
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
GLYCOPYRROLATE 2026-01-19
Labeling
GLYCOPYRROLATE 2026-01-19
Labeling
GLYCOPYRROLATE 2025-12-23
GLYCOPYRROLATE 2025-10-27
GLYCOPYRROLATE 2025-09-17
Labeling
GLYCOPYRROLATE 2025-08-11
Labeling
DOXEPIN HYDROCHLORIDE 2025-08-06
GLYCOPYRROLATE 2025-07-16
Efficacy
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (2)
Company Info
- First Approval
- 1991-10-08
- Latest
- 2023-06-08
- Applications
- 5